HomeNewsIndiaCovid-19 surge in India: Active cases rise to 4,026; five deaths reported in 24 hours

Covid-19 surge in India: Active cases rise to 4,026; five deaths reported in 24 hours

The fatalities were recorded in Kerala, Maharashtra, Tamil Nadu, and West Bengal, all involving patients with underlying health conditions.

June 03, 2025 / 09:34 IST
Story continues below Advertisement
India’s active COVID-19 caseload has increased to 4,026, with five more deaths reported in the last 24 hours (as of 8 am, Tuesday).
India’s active COVID-19 caseload has increased to 4,026, with five more deaths reported in the last 24 hours (as of 8 am, Tuesday).

India’s active COVID-19 caseload has increased to 4,026, with five more deaths reported in the last 24 hours (as of 8 am, Tuesday), according to the Ministry of Health and Family Welfare. The fatalities were recorded in Kerala, Maharashtra, Tamil Nadu, and West Bengal, all involving patients with underlying health conditions.

Kerala reported the death of an 80-year-old man with severe pneumonia and acute respiratory distress syndrome (ARDS), in addition to diabetes, hypertension, and coronary artery disease. Maharashtra recorded two deaths - a 70-year-old woman with diabetes and another 73-year-old woman with both diabetes and hypertension.

Story continues below Advertisement

In Tamil Nadu, a 69-year-old woman with Type 2 diabetes and Parkinson’s disease succumbed to the virus. West Bengal reported the death of a 43-year-old woman who was suffering from acute coronary syndrome, septic shock, and acute kidney injury.

The latest wave is being attributed to the highly transmissible NB.1.8.1 sub-variant, a descendant of the Omicron lineage.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show